Clinical trial
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 · Ullevaal University Hospital, Other · Completed
Key facts
| NCT number | NCT00222261 |
|---|---|
| Title | Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. |
| Official title | Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. |
| Acronym | ASCET |
| Lead sponsor | Ullevaal University Hospital, Other |
| Collaborators | The Norwegian Council for Cardiovascular Diseases. Ada and Hagbart Waages Humanitarian and Charity Foundation Alf and Aagot Helgesens Research Foundation. |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease, Angina Pectoris, Atherosclerosis |
| Intervention type | Drug |
| Interventions | aspirin, clopidogrel |
| Enrollment | 1,001 |
| Start date | Apr 1, 2003 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 23, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: